Clinical Trial Update: Cognitive Therapy for Negative Symptoms and Functioning [Phase 2]

View source ↗

Summary

Phase 2 study evaluating cognitive therapy to reduce negative symptoms and improve functioning in schizophrenia and schizoaffective disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: University of Pennsylvania | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: COMPLETED